Found "AI": 1,091 results
Sort by
Last updated

Introduction of Pneumococcal Conjugate Vaccine (PCV) in Bhutan

In September 2016, Bhutan Ministry of Health (MOH) approached HITAP to provide support to conduct an economic evaluation study to introduce PCV in Bhutan. With regards to the request, WHO Bhutan funded 4 of HITAP staffs (3 researchers and 1 project associate) to help conduct the study. This collaborative work between MOH, HITAP and WHO has a work p

GAVI Health Systems Strengthening Support (HSS) Study

The World Health Organization (WHO) requested HITAP to provide technical assistance to the Ministry of Health and Sports (MoHS) in Myanmar to complete a closure assessment of two health financing schemes under the GAVI Health Systems Strengthening Support (HSS) program. The study will apply a multi-pronged approach comprising a document review, a s

An evaluation of a program promoting access to school health services in the context of Thai local authority’s primary schools

11-3-103-2559local authority,primary school,school health services,นักเรียน,บริการอนามัยโรงเรียน,องค์กรปกครองส่วนท้องถิ่น,โรงเรียน

The Impact of Health Technology Assessment for the Support of Universal Health Coverage in Thailand

According to World Health Organization (WHO) health system framework an efficient health system results in equitable access to essential health technologies with assured quality, safety, efficacy, and cost-effectiveness. National policies, essential health technology list, and evidenced-based selection of health technologies using health technology

Development of health promotion model for economic evaluation in Thailand: a case study of alcohol control interventions

The evaluation of health promotion interventions has also become increasingly important in Thailand, particularly evaluation of effectiveness and cost-effectiveness (Room et al. 2003). The past evaluations of ThaiHealth were the assessment of intermediate outcome e.g. alcohol consumption per capita, individual alcohol drinking pattern, aggregate al

COVID-19 Multi-Model Comparison Consortium (CMCC)

The CMCC aims to enhance the informed use of COVID-19 models in policy making, by providing end users (with focus on LMICs) with an accessible overview of the aims, capabilities and limits of the existing COVID-19 models, how projections differ and what the models’ key assumptions/drivers are. The CMCC is convened by BMGF, the Centers for Disease
10 / Page